Estimating Return on Investment in Translational Research: Methods and Protocols

Kyle L. Grazier, William M. Trochim, David Dilts, Rosalind Kirk

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Assessing the value of clinical and translational research funding on accelerating the translation of scientific knowledge is a fundamental issue faced by the National Institutes of Health (NIH) and its Clinical and Translational Awards (CTSAs). To address this issue, the authors propose a model for measuring the return on investment (ROI) of one key CTSA program, the clinical research unit (CRU). By estimating the economic and social inputs and outputs of this program, this model produces multiple levels of ROI: investigator, program, and institutional estimates. A methodology, or evaluation protocol, is proposed to assess the value of this CTSA function, with specific objectives, methods, descriptions of the data to be collected, and how data are to be filtered, analyzed, and evaluated. This article provides an approach CTSAs could use to assess the economic and social returns on NIH and institutional investments in these critical activities.

Original languageEnglish (US)
Pages (from-to)478-491
Number of pages14
JournalEvaluation and the Health Professions
Volume36
Issue number4
DOIs
StatePublished - Dec 2013

Fingerprint

Translational Medical Research
National Institutes of Health (U.S.)
Economics
Research Personnel
Research

Keywords

  • evaluation
  • return on research investment
  • ROI

ASJC Scopus subject areas

  • Health Policy

Cite this

Estimating Return on Investment in Translational Research : Methods and Protocols. / Grazier, Kyle L.; Trochim, William M.; Dilts, David; Kirk, Rosalind.

In: Evaluation and the Health Professions, Vol. 36, No. 4, 12.2013, p. 478-491.

Research output: Contribution to journalArticle

Grazier, Kyle L. ; Trochim, William M. ; Dilts, David ; Kirk, Rosalind. / Estimating Return on Investment in Translational Research : Methods and Protocols. In: Evaluation and the Health Professions. 2013 ; Vol. 36, No. 4. pp. 478-491.
@article{56f33f6dac6048d7834c4902ce40fc02,
title = "Estimating Return on Investment in Translational Research: Methods and Protocols",
abstract = "Assessing the value of clinical and translational research funding on accelerating the translation of scientific knowledge is a fundamental issue faced by the National Institutes of Health (NIH) and its Clinical and Translational Awards (CTSAs). To address this issue, the authors propose a model for measuring the return on investment (ROI) of one key CTSA program, the clinical research unit (CRU). By estimating the economic and social inputs and outputs of this program, this model produces multiple levels of ROI: investigator, program, and institutional estimates. A methodology, or evaluation protocol, is proposed to assess the value of this CTSA function, with specific objectives, methods, descriptions of the data to be collected, and how data are to be filtered, analyzed, and evaluated. This article provides an approach CTSAs could use to assess the economic and social returns on NIH and institutional investments in these critical activities.",
keywords = "evaluation, return on research investment, ROI",
author = "Grazier, {Kyle L.} and Trochim, {William M.} and David Dilts and Rosalind Kirk",
year = "2013",
month = "12",
doi = "10.1177/0163278713499587",
language = "English (US)",
volume = "36",
pages = "478--491",
journal = "Evaluation and the Health Professions",
issn = "0163-2787",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Estimating Return on Investment in Translational Research

T2 - Methods and Protocols

AU - Grazier, Kyle L.

AU - Trochim, William M.

AU - Dilts, David

AU - Kirk, Rosalind

PY - 2013/12

Y1 - 2013/12

N2 - Assessing the value of clinical and translational research funding on accelerating the translation of scientific knowledge is a fundamental issue faced by the National Institutes of Health (NIH) and its Clinical and Translational Awards (CTSAs). To address this issue, the authors propose a model for measuring the return on investment (ROI) of one key CTSA program, the clinical research unit (CRU). By estimating the economic and social inputs and outputs of this program, this model produces multiple levels of ROI: investigator, program, and institutional estimates. A methodology, or evaluation protocol, is proposed to assess the value of this CTSA function, with specific objectives, methods, descriptions of the data to be collected, and how data are to be filtered, analyzed, and evaluated. This article provides an approach CTSAs could use to assess the economic and social returns on NIH and institutional investments in these critical activities.

AB - Assessing the value of clinical and translational research funding on accelerating the translation of scientific knowledge is a fundamental issue faced by the National Institutes of Health (NIH) and its Clinical and Translational Awards (CTSAs). To address this issue, the authors propose a model for measuring the return on investment (ROI) of one key CTSA program, the clinical research unit (CRU). By estimating the economic and social inputs and outputs of this program, this model produces multiple levels of ROI: investigator, program, and institutional estimates. A methodology, or evaluation protocol, is proposed to assess the value of this CTSA function, with specific objectives, methods, descriptions of the data to be collected, and how data are to be filtered, analyzed, and evaluated. This article provides an approach CTSAs could use to assess the economic and social returns on NIH and institutional investments in these critical activities.

KW - evaluation

KW - return on research investment

KW - ROI

UR - http://www.scopus.com/inward/record.url?scp=84887427597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887427597&partnerID=8YFLogxK

U2 - 10.1177/0163278713499587

DO - 10.1177/0163278713499587

M3 - Article

C2 - 23925706

AN - SCOPUS:84887427597

VL - 36

SP - 478

EP - 491

JO - Evaluation and the Health Professions

JF - Evaluation and the Health Professions

SN - 0163-2787

IS - 4

ER -